Bausch Health Companies (TSE:BHC) Shares Up 3% – Still a Buy?

Shares of Bausch Health Companies Inc. (TSE:BHC) shot up 3% on Thursday . The company traded as high as C$11.67 and last traded at C$11.61. 76,142 shares were traded during trading, a decline of 44% from the average session volume of 137,096 shares. The stock had previously closed at C$11.27.

Wall Street Analysts Forecast Growth

Separately, Evercore ISI raised shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

Bausch Health Companies Price Performance

The stock has a market capitalization of C$4.18 billion, a PE ratio of -6.50, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77. The business’s 50-day moving average price is C$11.61 and its 200 day moving average price is C$10.21. The company has a debt-to-equity ratio of 7,583.76, a quick ratio of 0.58 and a current ratio of 1.19.

Bausch Health Companies (TSE:BHC) last posted its earnings results on Wednesday, October 30th. The company reported C$1.53 EPS for the quarter, topping the consensus estimate of C$1.43 by C$0.10. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%. The business had revenue of C$3.42 billion during the quarter, compared to analysts’ expectations of C$3.36 billion. Research analysts forecast that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.